CompoAtlas

Nasodren

Natural health product licensed in Canada

Licence holder
Averroes Trading Canada Inc.
NPN or DIN-HM
80125403
Status
Active licence
Licence date
6 July 2023
Revision date
Not provided
Form
Vaporisateur
Route of administration
Nasale
Application type
Générale (non traditionelle)

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Cyclamen purpurascens1.3 mg

Non-medicinal ingredients

Eau

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years2 Pulvérisateur1 Tous les jours
Enfants et Adolescentsminimum: 12 years ; maximum: 17 years2 Pulvérisateur1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to clear the nose and sinuses by mucus drain - All groups Indicated for the treatment of Acute and Chronic Rhinosinusitis - Adults 18 years and older Symptomatic relieve of sinus and nasal congestion - Adults 18 years and older Symptomatic relieve of sinus and nasal congestion in children - Children and adolescents 12 - 17 years

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80125403

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line